Shri Jayanthi Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.50 M
- Company Age 3 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.00 Cr
- Revenue Growth 1159.05%
- Profit Growth 128.87%
- Ebitda 825.08%
- Net Worth 24.69%
- Total Assets 55.81%
About Shri Jayanthi Pharma
Shri Jayanthi Pharma Private Limited (SJPPL) is a Private Limited Indian Non-Government Company incorporated in India on 23 November 2021 (Three years and two months 10 days old ). Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M.
The company currently has active open charges totaling ₹3.00 Cr.
Senthilnathan Ganesan, Sambandam Subramaniam, Karuppiah Kumarappan, and One other member serve as directors at the Company.
Company Details
-
Location
Chennai, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51909TN2021PTC148088
-
Company No.
148088
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
23 Nov 2021
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Shri Jayanthi Pharma?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Senthilnathan Ganesan
|
Director | 23-Nov-2021 | Current |
|
Sambandam Subramaniam
|
Director | 23-Nov-2021 | Current |
|
Karuppiah Kumarappan
|
Director | 23-Nov-2021 | Current |
|
Karuppan Muthukaruppan
|
Director | 23-Nov-2021 | Current |
Financial Performance of Shri Jayanthi Pharma.
Shri Jayanthi Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 1159.05% increase. The company also saw a substantial improvement in profitability, with a 128.87% increase in profit. The company's net worth Soared by an impressive increase of 24.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shri Jayanthi Pharma?
In 2023, Shri Jayanthi Pharma had a public holding of 48.83%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Ampturn Electrical Products Private LimitedSenthilnathan Ganesan is a mutual person
-
Viriya Energy Solutions LlpKaruppan Muthukaruppan is a mutual person
-
Karupar Investments And Finance Private Limited
Karuppan Muthukaruppan is a mutual person
Charges (Loans)
₹30.00 M
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 3.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Dec 2022 | Axis Bank Limited | ₹3.00 Cr | Open |
How Many Employees Work at Shri Jayanthi Pharma?
Shri Jayanthi Pharma has a workforce of 23 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shri Jayanthi Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shri Jayanthi Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.